MX9709098A - Analogos quimericos de cuerpo graso-pro con potencia biologica incrementada. - Google Patents

Analogos quimericos de cuerpo graso-pro con potencia biologica incrementada.

Info

Publication number
MX9709098A
MX9709098A MX9709098A MX9709098A MX9709098A MX 9709098 A MX9709098 A MX 9709098A MX 9709098 A MX9709098 A MX 9709098A MX 9709098 A MX9709098 A MX 9709098A MX 9709098 A MX9709098 A MX 9709098A
Authority
MX
Mexico
Prior art keywords
grf
pro
fatty body
grf analogs
increased biological
Prior art date
Application number
MX9709098A
Other languages
English (en)
Other versions
MXPA97009098A (es
Inventor
Michel Ibea
Thierry Abritat
Paul Brazeau
Original Assignee
Theratechnologies Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27036979&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX9709098(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Theratechnologies Inc filed Critical Theratechnologies Inc
Publication of MX9709098A publication Critical patent/MX9709098A/es
Publication of MXPA97009098A publication Critical patent/MXPA97009098A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/60—Growth-hormone releasing factors (GH-RF) (Somatoliberin)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/25—Growth hormone-releasing factor [GH-RF] (Somatoliberin)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/12—Growth hormone, growth factor other than t-cell or b-cell growth factor, and growth hormone releasing factor; related peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Hematology (AREA)
  • Toxicology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Epidemiology (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)

Abstract

La presente invencion se refiere a análogos de cuerpo graso quimérico-pro-FRC con potencia biologica incrementada, su aplicacion como agentes anabolicos y el diagnostico y tratamiento de deficiencias de la hormona del crecimiento, Los análogos de cuerpo pueden preparar ya sea uniendo uno o varios aminoácidos por un residuo psedomicelar en la síntesis química de RFC. Los análogos de FRC de la presente invencion son biodegradables, no inmunogénicos y exhiben una potencia anabolica mejorada con una dosis reducida y actividad prolongada.
MXPA/A/1997/009098A 1995-05-26 1997-11-25 Analogos quimericos de cuerpo graso-pro con potencia biologica incrementada MXPA97009098A (es)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US45306795A 1995-05-26 1995-05-26
US453067 1995-05-26
US65164596A 1996-05-22 1996-05-22
US651645 1996-05-22

Publications (2)

Publication Number Publication Date
MX9709098A true MX9709098A (es) 1998-06-30
MXPA97009098A MXPA97009098A (es) 1998-10-30

Family

ID=

Also Published As

Publication number Publication date
KR100543190B1 (ko) 2006-06-23
DE69614849T2 (de) 2002-05-16
EP0828758B1 (en) 2001-08-29
CA2222068C (en) 2007-04-10
ES2163020T3 (es) 2002-01-16
EP0828758A1 (en) 1998-03-18
US5939386A (en) 1999-08-17
CA2222068A1 (en) 1996-11-28
BR9608799A (pt) 1999-12-07
BR9608799B1 (pt) 2009-12-01
BRPI9608799B8 (pt) 2019-11-05
DE69614849D1 (de) 2001-10-04
JPH11505807A (ja) 1999-05-25
AU5683396A (en) 1996-12-11
DK0828758T3 (da) 2002-01-07
KR19990021938A (ko) 1999-03-25
ATE204881T1 (de) 2001-09-15
JP3576170B2 (ja) 2004-10-13
AU697119B2 (en) 1998-09-24
WO1996037514A1 (en) 1996-11-28
US5861379A (en) 1999-01-19
PT828758E (pt) 2002-02-28

Similar Documents

Publication Publication Date Title
CA2222068A1 (en) Chimeric fatty body-pro-grf analogs with increased biological potency
WO2000014236A3 (en) Grf analogs with increased biological potency
HUT69178A (en) Process for producing peptides of growth hormone releasing activity
GB8922026D0 (en) Novel anti-viral and cytotoxic agent
EP0268533A3 (en) Composition for feeding ruminants which contains a biologically active substance, and its preparation
EP0152148A3 (en) Pharmaceutica composition for the treatment of acute myocardial ischemia
RU93005051A (ru) Способ получения катионных кристаллов гр или производных гр, катионные кристаллы человеческого гр или производных человеческого гр, фармацевтические препараты, использование процесса кристаллизации
DK193887D0 (da) Fysiologisk aktivt peptid
HK1006154A1 (en) Pharmaceutic composition based on diphoshonates for the treatment of the arthrosis
TW286320B (es)
ES2002083A6 (es) Un metodo para preparar derivados de piroglutamida
GR3014916T3 (en) Peptide compounds having growth hormone releasing activity.
DE2547721A1 (de) Biologisch aktive amide
US3670079A (en) Anabolic agents
ES8700054A1 (es) Procedimiento de obtencion de germicidas a base de acidos clorhidrico y fosforico.
CA2072797A1 (en) Use of tri (n-butyl) phosphate at low ph in solutions of biologically active proteins for enhanced virucidal activity
IL85029A (en) Microcrystalline cis diammineplatinum(ii)complex of 1,1-cyclobutanedicarboxylic acid,its preparation and cytostatic pharmaceutical compositions containing it
DE3370026D1 (en) Biologically active conjugates and their preparation and use
GB8808201D0 (en) Animal feeders & agricultural trailers
IL84758A0 (en) Peptides stimulating the release of pituitary growth hormone in fish and amphibians,and pharmaceutical compositions containing them
BG102476A (en) Polymorphous forms of secretagogue of growth hormone
ATE39697T1 (de) Erythromycin-a-salz mit mucosecretolytischer und fluidisierender aktivitaet, verfahren zu seiner herstellung und dieses enthaltende pharmazeutische zusammensetzungen.
UA19786A (uk) Засіб для обробки бульб кортоплі перед посадкою
IL78609A0 (en) Utilizing of straw as animal feed
UA13500A (uk) Спосіб запобігання негативному впливу магнітних бур на організм лактуючих корів